These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4241157)

  • 1. Further kinetic studies on the inhibition of fibrinolysis by synthetic inhibitors.
    Iwamoto M; Abiko Y
    J Biochem; 1969 May; 65(5):821-3. PubMed ID: 4241157
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasminogen-plasmin system. 3. Kinetics of plasminogen activation and inhibition of plasminogen-plasmin system by some synthetic inhibitors.
    Iwamoto M; Abiko Y; Shimizu M
    J Biochem; 1968 Dec; 64(6):759-67. PubMed ID: 4238017
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 4. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
    Thorsen S; Astrup T
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
    Okamoto S; Oshiba S; Mihara H; Okamoto U
    Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270
    [No Abstract]   [Full Text] [Related]  

  • 6. Tranexamic acid and fibrinolytic activity of the vessel wall.
    Astedt B; Liedholm P
    Experientia; 1974 Jul; 30(7):776-7. PubMed ID: 4847668
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative assessment of fibrinolysis on isolated glomeruli.
    Sraer JD; Boelaert J; Mimoune O; Morel-Maroger L; Hornych H
    Kidney Int; 1973 Nov; 4(5):350-2. PubMed ID: 4762582
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of plasmin system by 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006) (AUTHOR'S TRANSL)].
    Maki M
    Rinsho Ketsueki; 1972 Feb; 13(1):30-7. PubMed ID: 4281839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolysis activities and factor XIII in the neonatal period. 2. Relationship between factor XIII and fibrinolysis activities].
    Yamada Z
    Nihon Shonika Gakkai Zasshi; 1971 Apr; 75(4):297-303. PubMed ID: 4252803
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
    Abiko Y; Iwamoto M
    Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the significance of secondary fibrinolysis in experimental DIC (author's transl)].
    Goto H
    Nihon Seirigaku Zasshi; 1973 Jun; 35(6):295-306. PubMed ID: 4270923
    [No Abstract]   [Full Text] [Related]  

  • 14. On the heterogeneity of activity by various types of plasmins and the spectra of inhibition of some plasmin inhibitors.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):67-85. PubMed ID: 4257701
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.
    Andersson L; Nilsoon IM; Colleen S; Granstrand B; Melander B
    Ann N Y Acad Sci; 1968 Jun; 146(2):642-58. PubMed ID: 5254275
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibitory effect of 4-(2-carboxyethyl) phenyl trans-4-aminomethyl cyclohexane carboxylate hydrochloride on fibrinolysis, esterolysis and proteolysis and its degradation by serum esterases: in vitro study].
    Nagamatsu Y; Matsumoto M; Yamamoto J; Okamoto U
    Nihon Ketsueki Gakkai Zasshi; 1973 Apr; 36(2):150-8. PubMed ID: 4738466
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasminogen-plasmin system. V. A stoichiometric equilibrium complex of plasminogen and a synthetic inhibitor.
    Abiko Y; Iwamoto M; Tomikawa M
    Biochim Biophys Acta; 1969; 185(2):424-31. PubMed ID: 4241289
    [No Abstract]   [Full Text] [Related]  

  • 19. Tranexamic acid and gastric fibrinolysis in the rat.
    Stenberg B; Risberg B; Peterson HI
    Thromb Haemost; 1980 Feb; 42(5):1425-8. PubMed ID: 7368148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of fibrinolysin T activity fails to restore density-dependent growth inhibition to SV3T3 cells.
    Chou IN; Black PH; Roblin RO
    Nature; 1974 Aug; 250(5469):739-41. PubMed ID: 4370416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.